XERS · Categories · Form 4
XERS - SEC Form 4 insider transactions
Xeris Biopharma Holdings Inc. (XERS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for XERS
- Officer Hecht Beth sold $103,805 worth of shares (16,667 units at $6.23) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,193,173 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- SEC Form 4 filed by Hecht Beth4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- SEC Form 4 filed by Brady James Aloysius4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin exercised 48,898 shares at a strike of $4.09, increasing direct ownership by 3% to 1,777,725 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Pieper Steven exercised 41,927 shares at a strike of $4.71, increasing direct ownership by 3% to 1,408,940 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth sold $104,086 worth of shares (16,667 units at $6.25), decreasing direct ownership by 1% to 1,226,507 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Nguyen Anh Tu covered exercise/tax liability with 29,300 shares, decreasing direct ownership by 7% to 395,023 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr was granted 478,436 shares and covered exercise/tax liability with 340,505 shares, increasing direct ownership by 5% to 2,935,578 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin was granted 168,463 shares and covered exercise/tax liability with 126,062 shares, increasing direct ownership by 3% to 1,727,827 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Pieper Steven was granted 154,986 shares and covered exercise/tax liability with 205,534 shares, decreasing direct ownership by 4% to 1,367,013 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Nguyen Anh Tu was granted 121,293 shares, increasing direct ownership by 40% to 424,323 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth was granted 121,293 shares, covered exercise/tax liability with 169,555 shares and sold $124,147 worth of shares (16,667 units at $7.45), decreasing direct ownership by 5% to 1,243,174 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin sold $120,000 worth of shares (15,000 units at $8.00), decreasing direct ownership by 0.88% to 1,685,426 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr sold $176,257 worth of shares (24,907 units at $7.08) and exercised 92,301 shares at a strike of $1.63, increasing direct ownership by 2% to 2,797,647 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth sold $123,776 worth of shares (16,667 units at $7.43), decreasing direct ownership by 1% to 1,308,103 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Johnson John sold $977,019 worth of shares (135,400 units at $7.22), decreasing direct ownership by 16% to 698,083 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Bormann-Kennedy Barbara-Jean Anne sold $106,414 worth of shares (15,000 units at $7.09), decreasing direct ownership by 10% to 142,500 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth sold $116,781 worth of shares (16,667 units at $7.01), decreasing direct ownership by 1% to 1,320,176 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr exercised 96,070 shares at a strike of $1.55 and sold $173,402 worth of shares (23,242 units at $7.46), increasing direct ownership by 3% to 2,730,253 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth sold $123,296 worth of shares (16,667 units at $7.40), decreasing direct ownership by 1% to 1,336,843 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin covered exercise/tax liability with 733 shares, decreasing direct ownership by 0.04% to 1,700,426 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin disposed of 2,000 shares (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Persky Marla sold $119,610 worth of shares (15,500 units at $7.72), decreasing direct ownership by 10% to 142,000 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Sherman Jeffrey W exercised 47,040 shares at a strike of $6.66 and sold $334,515 worth of shares (42,232 units at $7.92), increasing direct ownership by 2% to 219,188 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Johnson John sold $786,459 worth of shares (107,500 units at $7.32), decreasing direct ownership by 11% to 833,483 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Halkuff Dawn sold $309,226 worth of shares (42,500 units at $7.28), decreasing direct ownership by 27% to 115,000 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr covered exercise/tax liability with 36,918 shares, decreasing direct ownership by 1% to 2,657,425 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin covered exercise/tax liability with 14,651 shares, decreasing direct ownership by 0.85% to 1,701,159 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Bormann-Kennedy Barbara-Jean Anne was granted 50,000 shares, increasing direct ownership by 47% to 157,500 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Persky Marla was granted 50,000 shares, increasing direct ownership by 47% to 157,500 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Halkuff Dawn was granted 50,000 shares, increasing direct ownership by 47% to 157,500 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Sherman Jeffrey W was granted 50,000 shares, increasing direct ownership by 30% to 214,380 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Johnson John was granted 50,000 shares, increasing direct ownership by 6% to 940,983 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Kong Garheng was granted 50,000 shares, increasing direct ownership by 30% to 214,144 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin covered exercise/tax liability with 733 shares, decreasing direct ownership by 0.04% to 1,683,585 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Director Brady James Aloysius was granted 100,000 shares (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth sold $217,244 worth of shares (40,000 units at $5.43), decreasing direct ownership by 3% to 1,353,510 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin covered exercise/tax liability with 78,134 shares and was granted 185,000 shares, increasing direct ownership by 7% to 1,684,318 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr covered exercise/tax liability with 221,500 shares and was granted 800,000 shares, increasing direct ownership by 27% to 2,687,118 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth covered exercise/tax liability with 144,284 shares and was granted 185,000 shares, increasing direct ownership by 3% to 1,393,510 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Pieper Steven covered exercise/tax liability with 177,200 shares and was granted 185,000 shares, increasing direct ownership by 0.55% to 1,417,561 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Johnson Kenneth Erland covered exercise/tax liability with 41,318 shares, decreasing direct ownership by 11% to 320,446 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin covered exercise/tax liability with 24,501 shares, decreasing direct ownership by 2% to 1,577,452 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr covered exercise/tax liability with 39,443 shares, decreasing direct ownership by 2% to 2,108,618 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Johnson Kenneth Erland covered exercise/tax liability with 12,401 shares, decreasing direct ownership by 3% to 361,764 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Pieper Steven covered exercise/tax liability with 32,059 shares, decreasing direct ownership by 2% to 1,409,761 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth covered exercise/tax liability with 32,039 shares, decreasing direct ownership by 2% to 1,352,794 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Pieper Steven exercised 19,483 shares at a strike of $1.55, increasing direct ownership by 1% to 1,441,820 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Hecht Beth covered exercise/tax liability with 178,006 shares, decreasing direct ownership by 11% to 1,380,802 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Johnson Kenneth Erland covered exercise/tax liability with 74,904 shares, decreasing direct ownership by 17% to 373,036 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Pieper Steven covered exercise/tax liability with 204,575 shares, decreasing direct ownership by 13% to 1,422,337 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Shannon John Patrick Jr was granted 250,000 shares and covered exercise/tax liability with 271,551 shares, decreasing direct ownership by 0.99% to 2,148,061 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Officer Mcculloch Kevin was granted 150,000 shares, increasing direct ownership by 10% to 1,601,953 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Schmid John P. was granted 50,000 shares, increasing direct ownership by 79% to 113,159 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Fairley Ricki Louise was granted 50,000 shares, increasing direct ownership by 59% to 135,000 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Sherman Jeffrey W was granted 50,000 shares, increasing direct ownership by 44% to 164,380 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Bormann-Kennedy Barbara-Jean Anne was granted 50,000 shares, increasing direct ownership by 87% to 107,500 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Johnson John was granted 50,000 shares, increasing direct ownership by 6% to 890,983 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Persky Marla was granted 50,000 shares, increasing direct ownership by 87% to 107,500 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Kong Garheng was granted 50,000 shares, increasing direct ownership by 44% to 164,144 units (SEC Form 4)4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)